ROTOVAC
Bharat Bio's Rotavirus vaccine Rotavac may be unsafe for children: StudyA study found that Bharat Biotech's Rotavac vaccine used in the government's immunization program increases the risk of intussusception in ...
Bharat Biotech likely to be valued at $600 million as top PE firms queue up to buy stakeDomestic private equity fund ICICI Venture, International Finance Corp, the investment arm of World Bank, will exit their almost 10-yr inve...- Bharat Biotech to supply Rotavirus vaccine at $ 1Vaccine maker Bharat Biotech will supply India's first indigenously developed diarrhea vaccine to global markets and UN procurement agencie...
- Load More